Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.

Slides:



Advertisements
Similar presentations
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Advertisements

Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Beta blockers in the management of chronic kidney disease
Intensive hemodialysis—keeping the faith
Anemia management in chronic kidney disease
Impact of new dialysis solutions on peritonitis rates
Volume 64, Pages S72-S77 (November 2003)
Intensive hemodialysis—keeping the faith
Continuous renal replacement therapy in the critically ill patient
Reassessment of the care of the patient with chronic kidney disease
Progression of renal failure and hypertensive nephrosclerosis
Volume 63, Pages S88-S90 (June 2003)
C-reactive protein and dialysis access
Volume 70, Pages S21-S25 (December 2006)
George A. Kaysen, Burl R. Don
A new era in phosphate binder therapy: What are the options?
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Nephrology Crosswords: Hemodialysis
The epidemiology of chronic kidney disease
Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.
Edmund G. Lowrie  Kidney International 
Gentamicin pharmacokinetics during slow daily home hemodialysis
Study of Heart and Renal Protection (SHARP)
Volume 73, Pages S5-S17 (April 2008)
Body size and outcomes on peritoneal dialysis in the United States
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Blood pressure targets in hemodialysis patients
New insights in uremic toxins
The third World Kidney Day: Looking back and thinking forward
Effects of hemodialysis on cardiac function
Volume 64, Pages S72-S77 (November 2003)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier
Microbiology and outcomes of peritonitis in North America
Nephrology in Latin America, with special emphasis on Brazil
Alternate-day dialysis may be needed for hemodialysis patients
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
AGEs in foods: Do they play a role in uremia?
Volume 93, Issue 1, Pages (January 2018)
Simvastatin in nephrotic syndrome
Nephrology Crossword: Glomerulonephritis
Volume 56, Pages S29-S31 (November 1999)
Joachim Böhler, M.D., Johannes Donauer, Frieder Keller 
Volume 82, Issue 9, Pages (November 2012)
Daily nocturnal home hemodialysis
Peritoneal dialysis in Mexico
Current status of maintenance hemodialysis in Beijing, China
Phosphate binders on iron basis: A new perspective?
Organ transplantation goes to the movies
Volume 70, Pages S84-S90 (November 2006)
Volume 56, Pages S71-S74 (November 1999)
Volume 70, Issue 8, Pages (October 2006)
Volume 55, Pages S3-S16 (June 1999)
Volume 56, Pages S84-S87 (November 1999)
Volume 80, Issue 10, Pages (November 2011)
Volume 64, Issue 5, Pages (November 2003)
Angiotensin II modulates cellular functions of podocytes
Volume 56, Pages S41-S45 (November 1999)
Volume 56, Pages S37-S40 (November 1999)
Charles A. Herzog  Kidney International 
Is complement a target for therapy in renal disease?
Volume 70, Issue 5, Pages (September 2006)
Volume 70, Issue 10, Pages (November 2006)
The International Pediatric Peritonitis Registry: Starting to walk
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Presentation transcript:

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van de Loo, Joachim Böhler  Kidney International  Volume 56, Pages S46-S50 (November 1999) DOI: 10.1046/j.1523-1755.56.s72.2.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Time course of platelet counts. Day 0 is the day of platelet count nadir in all patients. Kidney International 1999 56, S46-S50DOI: (10.1046/j.1523-1755.56.s72.2.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.